Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results, is ...

StockNews.com assumed coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the medical equipment provider’s stock. Other equities ...

Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment ...

Nevro Corp. price-consensus-eps-surprise-chart | Nevro Corp. Quote In the quarter under review ... 14.5% during after-market trading. However, the stock plunged 75.3% year to date against the ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro ... stock. Globus Medical has a market capitalization of $11.93 billion. Going by the Zacks Consensus Estimate, the ...

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. On a per-share basis, the Redwood City, California ...

Nevro Corp is set to release its Q4 2024 earnings on Mar 4, 2025.The consensus estimate for Q4 2024 revenue is $102.54 million, and the earnings are expected to come in at -$0.79 per share. The ...

In recent months, several firms have downgraded their ratings or lowered their price targets for Nevro stock. These adjustments reflect concerns about the company's ability to reverse the trend of ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 ...